A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

This publication has 25 references indexed in Scilit:

• Effect of Surgeon Specialty on Processes of Care and Outcomes for Ovarian Cancer Patients
  JNCI Journal of the National Cancer Institute, 2006
• Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals
  International Journal of Gynecologic Cancer, 2006
• Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma
  Cancer, 2005
• Who should operate on patients with ovarian cancer? An evidence-based review
  Gynecologic Oncology, 2005
• Human Epididymis Protein 4 (HE4) Is a Secreted Glycoprotein that Is Overexpressed by Serous and Endometrioid Ovarian Carcinomas
  Cancer Research, 2005
• A Population-Based Study of Patterns of Care for Ovarian Cancer: Who Is Seen by a Gynecologic Oncologist and Who Is Not?
  Gynecologic Oncology, 2002
• Stage IV Ovarian Cancer: Impact of Surgical Debulking1
  Gynecologic Oncology, 1997
• Prospective Multicenter Study on CA 125 in Postmenopausal Pelvic Masses
  Gynecologic Oncology, 1994
• A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer
  BJOG: An International Journal of Obstetrics and Gynaecology, 1990
• A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
  New England Journal of Medicine, 1983